Dendrite Launches First Source Sales Applications Suite Providing Pharmaceutical and Life Sciences Companies with Advanced Sales Force Effectiveness Tools.

BEDMINSTER, N.J. -- Completely Redesigned Suite Uses an Innovative Human-Centered Design User Interface and Microsoft's .NET Technology Platform to Maximize Productivity and Enterprise Integration

Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of sales, marketing, clinical, and compliance solutions for the life sciences and pharmaceutical industry, today launched the First Source Sales Applications(TM) ("FSSA") solution set, the next-generation of the company's industry-leading sales effectiveness solutions. FSSA enables companies to take advantage of a revolutionary, human-centered designed front-end to improve sales force effectiveness and a technology platform constructed on Microsoft's .NET to maximize enterprise integration and user productivity.

The new FSSA suite has been greatly improved through the application of human-centered design principles, a design process that observes users in their own environment and accurately captures the work flow that is then designed into the software. New FSSA tools designed with human-centered principles, such as mobile applications, analytics, administration and integration solutions, enable sales representatives to work more efficiently so they can spend more time building relationships with customers.

"Because big pharma faces an inflection point in its approach to marketing, the CRM solutions they choose must match their unique selling environment," said Charles Firneno, a Research Manager with market research firm Life Science Insights, an IDC Company. "As the blockbuster model evolves into more targeted therapeutics, requiring greater agility in managing field resources, drug companies will need better integrated, industry-specific, solutions. By delivering a functionally integrated solution designed using reps in the field, Dendrite reaffirms the value of focus in pharmaceutical CRM."

FSSA also provides sales forces with more options, as the suite can be deployed on a variety of hardware platforms including PDAs, tablets, slates and laptops. Customers also have the option of deploying the technology in a Web-based (connected) mode or an off-line (disconnected) configuration.

Dendrite chose to build its next generation application suite on the Microsoft .NET platform to meet the growing needs of its customers who wanted a flexible, fully open architecture.

"By combining our new human-centered design user interface with a strong solution architecture built on .NET, Dendrite enables life science and pharmaceutical companies of any size to improve field sales performance and lower IT costs through investment reuse," said Dave Escalante, Vice President of Product Management at Dendrite. "Our new sales force effectiveness suite sets a new standard for CRM innovation in the industry."

The FSSA suite, which is designed to improve sales force effectiveness across sales divisions and regions, allows companies to integrate clinical, marketing, sales and finance information to provide sales representatives with a comprehensive view of their customers across coordinated sales and marketing activities.

"Dendrite's First Source Sales Applications improve business ROI by providing a substantially enhanced level of customer intimacy, helping ensure that pharmaceutical companies can fully maximize sales efforts and the potential of their investment in supporting solutions," said Dendrite Chief Operating Officer Paul Zaffaroni.

FSSA is a comprehensive, fully integrated and flexible suite of products, providing the ability to dramatically enhance sales force effectiveness. Components include:

--Mobile Intelligence(TM): With its robust set of customer relationship management functions, the Mobile Intelligence sales effectiveness software promotes team and targeted selling through integrated, multi-channel customer management capabilities. Sales representatives receive an enhanced user experience utilizing the new user interface, which maps to their actual day-to-day workflow.

--Analyzer(TM): A flexible, easy-to-use data viewing and analysis tool that standardizes the decision support and reporting process for all levels of a sales organization. Analyzer enables sales representatives to track the effects of their promotional activities and enables managers to achieve sales objectives, assure call-plan compliance, and manage promotional program implementation.

--Organization Manager(R): Centralizes the management of sales representative roster, alignment and product data, enabling the efficient management of sales force information in order to effectively deploy and direct field sales resources in support of specific business objectives. Organization Manager enables Life Sciences companies to quickly and effectively respond to changing market conditions and business requirements by simplifying the task of capturing, maintaining and adjusting sales force alignment and demographic information to support complex sales structures, mirrored territories, and team selling.

--Sample Guardian(TM): A total management solution for accountability, exception tracking and maintenance of critical sample information. Sample Guardian provides robust functionality tools and strategic management capabilities that help companies comply with federal and state regulations. When integrated with Dendrite's Mobile Intelligence(TM), Sample Guardian enables pharmaceutical and life sciences companies to help enforce compliant behavior with field sales based on their specific business rules.

--Configuration Tools: A comprehensive toolset designed to manage Dendrite's new and innovative Life Sciences business application development platform. The tools enable companies to have more control and flexibility over their business applications, which result in improved overall timeliness, quality, and cost.

--Application Integration Server: A comprehensive set of integration technologies specifically designed to support Dendrite's new and innovative Life Sciences business application development platform. The Application Integration Server enables companies to integrate Dendrite business applications within their own environment and facilitate the sharing of information between applications resulting in improved overall data quality and information accessibility, at a lower cost.

In support of it new FSSA solution suite, Dendrite offers a complete set of support services, First Source Sales Support(TM). This best-in-class integrated set of services is designed to ensure successful customer relationship management (CRM) activities including the following:

--Implementation Services: Provides expertise and technical capabilities based on nearly 20 years of experience in the Life Sciences market.

--Managed Hosting Services: Provides total outsourcing services for all customer system components, including servers, databases, communication networks, and data processes housed within state-of-the-art Data Center facilities.

--Hardware & Asset Management Services: Provides certified solutions designed to minimize down time and optimize the productivity and success of sales and service professionals.

--Help Desk Services: With a customer-centric service approach, Dendrite's integrated help desk processes enable the delivery of consistent high level, field-user satisfaction.

--Learning & Collaborative Services -- Provides comprehensive training solutions to the Life Sciences industry through the use of experienced and proven processes that enable Dendrite to maximize training efficiency, effectiveness, and recall.

--Computer Systems Validation Services -- Extensive validation and Life Sciences industry experience provides our clients with custom-tailored validation solutions that achieve regulatory objectives, and assure cost-effective, efficient, and compliant operations.

About Dendrite

Pharmaceutical and other Life Sciences companies can look to Dendrite as their first source for expert, integrated global solutions that enhance the effectiveness of marketing, sales and clinical trial programs. For more information, visit www.dendrite.com.

This document may contain forward-looking statements that may be identified by such forward-looking terminology as "expect," "believe," "anticipate," "will," "intend," "plan," "target," "outlook," "guidance," and similar statements or variations. Such forward-looking statements are based on our current expectations, estimates, assumptions and projections and involve significant risks and uncertainties, including risks which may result from our dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy sales and implementation cycles for certain of our solutions; our fixed expenses in relation to fluctuating revenues and variations in customers' budget cycles; dependence on certain major customers; changes in demand for our products and services attributable to any weakness experienced in the economy or mergers, acquisitions and consolidations in the pharmaceutical industry; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; international operations; integrating the entities we acquire; our ability to effectively manage our growth; the protection of our proprietary technology; our ability to compete in the Internet-related products and services market; the continued demand for Internet-related products and services; the ability of our third party vendors to respond to technological change; our ability to maintain our relationships with third-party vendors; less favorable than anticipated results from strategic relationships; dependence of data solutions on strategic relationships; events which may affect the U.S. and world economies; and catastrophic events which could negatively affect our information technology infrastructure. Other important factors that should be reviewed and carefully considered are included in the company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The company assumes no obligation for updating any such forward-looking statements to reflect actual results, changes in assumptions or other changes affecting such forward-looking statements.

Note: Dendrite is a registered trademark of Dendrite International, Inc.